Hendricks County pitching motorsports skill, expertise to medical manufacturers
Hendricks County finds pay dirt pitching skills of racing industry to medical device manufacturers.
Life Science & Biotech
Articles
More patients help drug firms pass ‘valley of death’
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
The most likely conflict zone between Pence, Obama
Gov. Mike Pence thinks his HIP 2.0 plan would reform Medicaid in line with conservative principles. To the extent the Obama administration agrees, that’s the biggest hurdle to get the plan approved.
Small employers dumping plans faster than expected, WellPoint says
WellPoint saw 218,000 members of its health plans disappear because their employers ended their group plans. Other insurers, however, say small employers are ending their plans more slowly than expected.
Indiana health startups have raised $100M this year
Investors seem to have rediscovered the Midwest this year, pouring a record $777 million into 139 companies, according to BioEnterprise. In the first half of 2013, Midwest companies raised $351 million.
Should IU Health pursue a strategy of mediocrity?
Indiana University Health fell off U.S. News’ honor roll of the nation’s top 1 percent of hospitals. Because of Obamacare and other trends, perhaps IU Health should be happy about that.
Most drug money in Indiana funds research. Is that good?
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That’s not the same thing as paying to market drugs, but it’s hardly without controversy.
Med school plots researcher hiring spree
The Indiana University School of Medicine plans to hire 100 research professors over the next five years in a bid to vault into the top 25 medical schools.
If courts gut Obamacare, Pence will face tough choice
If this week’s D.C. appeals court ruling stands up—declaring the Obamacare tax subsidies illegal in Indiana and most other states—Gov. Mike Pence could face significant pressure, even from traditional Republican supporters, to keep the tax credits flowing.
Lilly sales, profit drop but beat analysts’ expectations
Indianapolis-based Lilly and Co. lost 17 percent of its revenue during the second quarter as U.S. patents expired on its bestselling drugs Cymbalta and Evista.
Dow Agro reports record second-quarter sales
Dow AgroSciences LLC posted sales of $1.9 billion in the second quarter, an increase of 3 percent over last year's second period, the Indianapolis-based company reported Wednesday morning.
Will hospitals’ higher facility fees survive health reform?
One of the open secrets in health care is that hospitals are paid substantially more than independently owned health care facilities for the same procedures. But those higher fees are facing unprecedented pressure.
Indy hospitals continue to see fewer patients. Why?
All of sudden, Hoosiers are buying less health care. Is that because we’ve kicked the habit, sobered up and found religion? Or is it the Great Recession hangover that will pass, eventually, so we can all get back to the party?
Indy patients love their doctors
Indianapolis ranked fifth highest among the nation’s largest cities for the most positive reviews of physicians. On a five-point Patient Happiness Index, the average review by patients scored Indianapolis physicians at a 4.05. San Francisco physicians topped the list.
Doctors’ drug money
Indiana physicians and research organizations reaped more than $25 million in payments from 15 pharmaceutical firms in 2012, according to the most recent data made available by the not-for-profit group ProPublica. Lilly was the biggest spender and the IU medical school was the biggest recipient.
Employees may rebel against Obamacare
The economics of the Obamacare’s exchanges are proving attractive to both employers and workers, but a new poll shows that workers still don’t want to end up in them.
Report: Indiana boasts four nation-leading life sciences clusters
The areas around each of Indiana’s research university campuses—Bloomington, Indianapolis, Lafayette and South Bend—all boast outsize concentration of life sciences workers. Yet the state still lags on research, development and investment funding.
There will be blood
A new study found that common blood tests performed by hospital-owned facilities in the Indianapolis area were six to nine times more expensive than the same tests at independent lab facilities. Ouch!
How to judge Obamacare
Health care and health insurance were a mess long before Obamacare—and on a path to getting messier. That makes it awfully difficult to figure out how much blame and credit to give the law as it plays out in the marketplace. Here's my approach.
Why hospitals leave the inner city, in one chart
Since hospitals lose money on just about every patient except those with private insurance, they have been closing inner-city facilities and opening new facilities in the suburbs for the past four decades.